{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T00:13:11Z","timestamp":1789863191169,"version":"4.0.1"},"reference-count":65,"publisher":"Informa UK Limited","issue":"10","content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Future Microbiol."],"published-print":{"date-parts":[[2015,10]]},"DOI":"10.2217\/fmb.15.91","type":"journal-article","created":{"date-parts":[[2015,10,6]],"date-time":"2015-10-06T10:34:27Z","timestamp":1444127667000},"page":"1579-1598","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":8,"title":["The Multicomponent Meningococcal Serogroup B Vaccine (4CMenB): Origin, Composition, Health Impact and Unknown Aspects"],"prefix":"10.1080","volume":"10","author":[{"given":"Chiara","family":"Mameli","sequence":"first","affiliation":[{"name":"Department of Pediatrics, Children\u2019s Hospital V. Buzzi, Via Castelvetro 32, University of Milan, Milan, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erica","family":"Galli","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Children\u2019s Hospital V. Buzzi, Via Castelvetro 32, University of Milan, Milan, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cecilia","family":"Mantegazza","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Children\u2019s Hospital V. Buzzi, Via Castelvetro 32, University of Milan, Milan, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valentina","family":"Fabiano","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Children\u2019s Hospital V. Buzzi, Via Castelvetro 32, University of Milan, Milan, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gian Vincenzo","family":"Zuccotti","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Children\u2019s Hospital V. Buzzi, Via Castelvetro 32, University of Milan, Milan, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2015,10,6]]},"reference":[{"key":"e_1_3_2_3_1","doi-asserted-by":"publisher","DOI":"10.1186\/1478-7954-11-17"},{"key":"e_1_3_2_4_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2011.12.032"},{"key":"e_1_3_2_5_1","doi-asserted-by":"publisher","DOI":"10.1097\/INF.0000000000000282"},{"key":"e_1_3_2_6_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(12)61187-8"},{"key":"e_1_3_2_7_1","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2334-10-175"},{"key":"e_1_3_2_8_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2013.03.063"},{"key":"e_1_3_2_9_1","unstructured":"World Health Organization . Immunization Vaccines and Biologicals. Meningococcal meningitis . www.who.int\/immunization\/research\/development\/meningitis\/en\/ ."},{"key":"e_1_3_2_10_1","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/126.5.514"},{"key":"e_1_3_2_11_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(09)70324-X"},{"key":"e_1_3_2_12_1","first-page":"177","article-title":"Development and evaluation of serogroup B serotype 2 protein vaccines: report of a serogroup B field trial","volume":"43","author":"Frasch CE","year":"1983","unstructured":"Frasch CE , CoetzeeG , ZahradnikJM , FeldmanHA , KoornhofHJ . Development and evaluation of serogroup B serotype 2 protein vaccines: report of a serogroup B field trial . Med. Trop.43 , 177 \u2013 183 ( 1983 ).","journal-title":"Med. Trop."},{"issue":"2","key":"e_1_3_2_13_1","first-page":"195","article-title":"Vaccine against group B Neisseria meningitidis: protection trial and mass vaccination results in Cuba","volume":"14","author":"Sierra GV","year":"1991","unstructured":"Sierra GV , CampaHC , VarcacelNMet al. Vaccine against group B Neisseria meningitidis: protection trial and mass vaccination results in Cuba . NIPH Ann.14 ( 2 ), 195 \u2013 207 ( 1991 ).","journal-title":"NIPH Ann."},{"key":"e_1_3_2_14_1","doi-asserted-by":"publisher","DOI":"10.1016\/0140-6736(91)91961-S"},{"key":"e_1_3_2_15_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2005.01.063"},{"key":"e_1_3_2_16_1","doi-asserted-by":"publisher","DOI":"10.1086\/501371"},{"key":"e_1_3_2_17_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.281.16.1520"},{"key":"e_1_3_2_18_1","doi-asserted-by":"publisher","DOI":"10.1586\/erv.11.103"},{"key":"e_1_3_2_19_1","doi-asserted-by":"publisher","DOI":"10.1126\/science.287.5459.1809"},{"key":"e_1_3_2_20_1","doi-asserted-by":"publisher","DOI":"10.1126\/science.287.5459.1816"},{"key":"e_1_3_2_21_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0603940103"},{"key":"e_1_3_2_22_1","doi-asserted-by":"publisher","DOI":"10.1128\/CDLI.10.5.780-786.2003"},{"key":"e_1_3_2_23_1","doi-asserted-by":"publisher","DOI":"10.1097\/INF.0b013e3181f59f6d"},{"key":"e_1_3_2_24_1","doi-asserted-by":"publisher","DOI":"10.1086\/656741"},{"key":"e_1_3_2_25_1","doi-asserted-by":"publisher","DOI":"10.1586\/14760584.2013.814862"},{"key":"e_1_3_2_26_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2012.01.033"},{"key":"e_1_3_2_27_1","doi-asserted-by":"publisher","DOI":"10.4161\/hv.7.7.15997"},{"key":"e_1_3_2_28_1","doi-asserted-by":"publisher","DOI":"10.4161\/hv.7.6.15482"},{"key":"e_1_3_2_29_1","doi-asserted-by":"publisher","DOI":"10.1128\/CVI.00304-10"},{"key":"e_1_3_2_30_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2012.85"},{"key":"e_1_3_2_31_1","doi-asserted-by":"publisher","DOI":"10.1503\/cmaj.130257"},{"key":"e_1_3_2_32_1","doi-asserted-by":"publisher","DOI":"10.1097\/INF.0b013e31829cfff2"},{"key":"e_1_3_2_33_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(12)61961-8"},{"key":"e_1_3_2_34_1","doi-asserted-by":"publisher","DOI":"10.4161\/hv.28666"},{"key":"e_1_3_2_35_1","doi-asserted-by":"publisher","DOI":"10.1503\/cmaj.141200"},{"key":"e_1_3_2_36_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(11)61713-3"},{"key":"e_1_3_2_37_1","doi-asserted-by":"publisher","DOI":"10.4161\/hv.25505"},{"key":"e_1_3_2_38_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(14)60842-4"},{"key":"e_1_3_2_39_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2009.04.065"},{"key":"e_1_3_2_40_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2006.03.091"},{"key":"e_1_3_2_41_1","unstructured":"European Medicines Agency . Bexsero: EPAR product information . http:\/\/www.ema.europa.eu\/ema\/index.jsp?curl=pages\/medicines\/human\/medicines\/002333\/human_med_001614.jsp&mid=WC0b01ac058001d124 ."},{"key":"e_1_3_2_42_1","unstructured":"Clinical Trials . Safety and immunogenicity in dose-ranging and formulation-finding meningococcal B (MenB) vaccine study in 2-month-old Infants . https:\/\/clinicaltrials.gov\/ct2\/show\/NCT00937521 ."},{"key":"e_1_3_2_43_1","unstructured":"European Medicine Agency . Bexerso: EPAR-Public assessment report . http:\/\/www.ema.europa.eu\/docs\/en_GB\/document_library\/EPAR_Public_assessment_report\/human\/002333\/WC500137883.pdf ."},{"key":"e_1_3_2_44_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2013.07.083"},{"key":"e_1_3_2_45_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1013758107"},{"issue":"2","key":"e_1_3_2_46_1","first-page":"56","article-title":"A combined approach to assess the potential coverage of a multicomponent protein-based vaccine","volume":"53","author":"Boccadifuoco G","year":"2012","unstructured":"Boccadifuoco G , BrunelliB , PizzaMG , GiulianiMM . A combined approach to assess the potential coverage of a multicomponent protein-based vaccine . J. Prev. Med. Hyg.53 ( 2 ), 56 \u2013 60 ( 2012 ).","journal-title":"J. Prev. Med. Hyg."},{"key":"e_1_3_2_47_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(13)70006-9"},{"issue":"15","key":"e_1_3_2_48_1","first-page":"00468","article-title":"MATS: Global coverage estimates for 4CMenB, a novel multicomponent meningococcal B vaccine","author":"Medini D","year":"2015","unstructured":"Medini D , StellaM , WassilJ . MATS: Global coverage estimates for 4CMenB, a novel multicomponent meningococcal B vaccine . Vaccinepii: S0264\u2013410X ( 15 ), 00468 \u2013 5 ( 2015 ).","journal-title":"Vaccine"},{"key":"e_1_3_2_49_1","unstructured":"National Foundation for Infectious Diseases . Addressing the challenges of serogroup B meningococcal disease outbreaks on campuses . http:\/\/www.nfid.org\/meningococcal-b ."},{"key":"e_1_3_2_50_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2015.06.046"},{"key":"e_1_3_2_51_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2013.08.006"},{"key":"e_1_3_2_52_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2011.11.050"},{"key":"e_1_3_2_53_1","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.03584-13"},{"key":"e_1_3_2_54_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2012.12.022"},{"key":"e_1_3_2_55_1","unstructured":"European Medicine Agency . Bexsero . www.ema.europa.eu\/docs\/en_GB\/document_library\/EPAR_Summary_for_the_public\/human\/002333\/WC500137857.pdf ."},{"key":"e_1_3_2_56_1","unstructured":"Australian Technical Advisory Group on Immunisation (ATAGI) Statement . Advice for immunisation providers regarding the use of Bexsero\u00ae \u2013 a recombinant multicomponent meningococcal B vaccine (4CMenB) . www.immunise.health.gov.au\/internet\/immunise\/publishing.nsf\/Content\/85A6879534C02B4DCA257B640002F38E\/$File\/ATAGI-advice-bexsero.pdf ."},{"key":"e_1_3_2_57_1","unstructured":"Health Canada . Bexsero . www.hc-sc.gc.ca\/dhp-mps\/prodpharma\/sbd-smd\/drug-med\/sbd_smd_2014_bexsero_147275-eng.php ."},{"key":"e_1_3_2_58_1","unstructured":"Instituto de Salud Publica Ministero da Salud Gobierno de Chile . Folleto de informacion al professional Bexsero vacuna meningococica recombinante adsorbida multicomponente del serogupo B suspension inyectable . http:\/\/www.ispch.cl\/sites\/default\/files\/bexsero_vacuna_meningococica.pdf ."},{"key":"e_1_3_2_59_1","unstructured":"US FDA . FDA approves a second vaccine to prevent serogroup B meningococcal disease . http:\/\/www.fda.gov\/NewsEvents\/Newsroom\/PressAnnouncements\/ucm431370.htm ."},{"key":"e_1_3_2_60_1","unstructured":"Sociedade Brasileira de Infectologia . http:\/\/www.infectologia.org.br\/posts-910\/ . Governo Federal licencia uso da vacina meningoc\u00f3cica B ."},{"key":"e_1_3_2_61_1","unstructured":"Istitut National de Sant\u00e9 Publique du Qu\u00e9bec . Initial Dose of a Multicomponent Serogroup B Meningococcal Vaccine in the Saguenay\u2013 Lac-Saint-Jean Region Qu\u00e9bec Canada: An Interim Safety Surveillance Report . https:\/\/www.inspq.qc.ca\/pdf\/publications\/1902_SerogroupB_Meningococcal_Vaccine.pdf ."},{"key":"e_1_3_2_62_1","unstructured":"Istitut National de Sant\u00e9 Publique du Qu\u00e9bec . R\u00e9sultats de la surveillance de la s\u00e9curit\u00e9 des premi\u00e8re et deuxi\u00e8me doses du vaccin contre le m\u00e9ningocoque de s\u00e9rogroupe B administr\u00e9 au Saguenay\u2013Lac-Saint-Jean . https:\/\/www.inspq.qc.ca\/pdf\/publications\/1975_Securite_Vaccin_Meningocoque_B.pdf ."},{"key":"e_1_3_2_63_1","doi-asserted-by":"publisher","DOI":"10.4161\/21645515.2014.971602"},{"key":"e_1_3_2_64_1","doi-asserted-by":"publisher","DOI":"10.1128\/CVI.00090-13"},{"key":"e_1_3_2_65_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2015.03.012"},{"key":"e_1_3_2_66_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2013.03.034"},{"key":"e_1_3_2_67_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0123383"}],"container-title":["Future Microbiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.2217\/fmb.15.91","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,23]],"date-time":"2024-06-23T06:41:12Z","timestamp":1719124872000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.2217\/fmb.15.91"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,10]]},"references-count":65,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2015,10]]}},"alternative-id":["10.2217\/fmb.15.91"],"URL":"https:\/\/doi.org\/10.2217\/fmb.15.91","relation":{},"ISSN":["1746-0913","1746-0921"],"issn-type":[{"value":"1746-0913","type":"print"},{"value":"1746-0921","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,10]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ifmb20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ifmb20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2015-10-06","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}